Breaking News Instant updates and real-time market news.

HPGLY

Hapag-Lloyd

$107.05 /

+ (+0.00%)

14:55
11/01/21
11/01
14:55
11/01/21
14:55

Hapag-Lloyd price target raised to EUR 151 from EUR 90.50 at JPMorgan

JPMorgan analyst Samuel Bland raised the firm's price target on Hapag-Lloyd to EUR 151 from EUR 90.50 and keeps an Underweight rating on the shares.

OTHER BREAKING NEWS FROM THE FLY

Conference/Events
Cowen Washington strategist to hold analyst/industry conference call » 11:30
12/08/22
12/08
11:30
12/08/22
11:30

Washington Strategist…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Periodicals
Tesla to shorten Shanghai output shifts, Bloomberg reports » 11:26
12/08/22
12/08
11:26
12/08/22
11:26
TSLA

Tesla

$171.26 /

-2.86 (-1.64%)

Tesla plans to shorten…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSLA Tesla
$171.26 /

-2.86 (-1.64%)

TSLA Tesla
$171.26 /

-2.86 (-1.64%)

12/07/22 Bernstein
Tesla may need to take additional price cuts in 2023, says Bernstein
12/05/22 Piper Sandler
If Tesla cuts production in China, it won't be due to competition, says Piper
11/29/22 Bernstein
Tesla risk/reward 'more balanced' after 48% drop, says Bernstein
11/28/22 Jefferies
XPeng downgraded to Underperform at Jefferies ahead of 'challenging year'
TSLA Tesla
$171.26 /

-2.86 (-1.64%)

TSLA Tesla
$171.26 /

-2.86 (-1.64%)

TSLA Tesla
$171.26 /

-2.86 (-1.64%)

TSLA Tesla
$171.26 /

-2.86 (-1.64%)

Options
SentinelOne call volume above normal and directionally bullish » 11:25
12/08/22
12/08
11:25
12/08/22
11:25
S

SentinelOne

$14.69 /

+0.715 (+5.12%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
S SentinelOne
$14.69 /

+0.715 (+5.12%)

S SentinelOne
$14.69 /

+0.715 (+5.12%)

07:06 Today Citi
SentinelOne price target lowered to $17 from $30 at Citi
12/07/22 DA Davidson
SentinelOne price target lowered to $22 from $40 at DA Davidson
12/07/22 BofA
SentinelOne price target lowered to $28 from $35 at BofA
12/07/22 JMP Securities
SentinelOne price target lowered to $36 from $42 at JMP Securities
S SentinelOne
$14.69 /

+0.715 (+5.12%)

S SentinelOne
$14.69 /

+0.715 (+5.12%)

S SentinelOne
$14.69 /

+0.715 (+5.12%)

S SentinelOne
$14.69 /

+0.715 (+5.12%)

Conference/Events
Blucora to participate in a conference call with Benchmark » 11:25
12/08/22
12/08
11:25
12/08/22
11:25
BCOR

Blucora

$23.88 /

-0.15 (-0.62%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCOR Blucora
$23.88 /

-0.15 (-0.62%)

BCOR Blucora
$23.88 /

-0.15 (-0.62%)

11/01/22 Barrington
Blucora price target raised to $30 from $25 at Barrington
07/11/22 Cantor Fitzgerald
Blucora initiated with an Overweight at Cantor Fitzgerald
07/11/22 Cantor Fitzgerald
Blucora initiated with an Overweight at Cantor Fitzgerald
06/27/22 Benchmark
Blucora 'a most interesting,' under-the-radar idea, says Benchmark
BCOR Blucora
$23.88 /

-0.15 (-0.62%)

BCOR Blucora
$23.88 /

-0.15 (-0.62%)

BCOR Blucora
$23.88 /

-0.15 (-0.62%)

Conference/Events
WeWork management to meet with BTIG » 11:25
12/08/22
12/08
11:25
12/08/22
11:25
WE

WeWork

$2.05 /

-0.085 (-3.99%)

Real Estate Investment…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WE WeWork
$2.05 /

-0.085 (-3.99%)

WE WeWork
$2.05 /

-0.085 (-3.99%)

11/04/22 BTIG
WeWork initiated with a Buy at BTIG
10/24/22 Cantor Fitzgerald
WeWork initiated with an Overweight at Cantor Fitzgerald
10/07/22 Piper Sandler
WeWork price target lowered to $7 from $10 at Piper Sandler
06/29/22 UBS
WeWork initiated with a Neutral at UBS
WE WeWork
$2.05 /

-0.085 (-3.99%)

WE WeWork
$2.05 /

-0.085 (-3.99%)

WE WeWork
$2.05 /

-0.085 (-3.99%)

Conference/Events
Cantor Fitzgerald pharma/biotech analyst hold a luncheon » 11:25
12/08/22
12/08
11:25
12/08/22
11:25
APLS

Apellis

$48.94 /

+1.27 (+2.66%)

, ISEE

Iveric bio

$21.08 /

+0.2 (+0.96%)

, JNJ

Johnson & Johnson

$177.38 /

+0.13 (+0.07%)

, NVS

Novartis

$91.10 /

-0.64 (-0.70%)

, AKTX

Akari Therapeutics

/

+

, BLTE

Belite Bio

$31.00 /

+0.6 (+1.97%)

, LCTX

Lineage Cell Therapeutics

$1.29 /

-0.02 (-1.53%)

, OCGN

Ocugen

$1.39 /

+0.015 (+1.09%)

, REGN

Regeneron

$774.25 /

+10.08 (+1.32%)

, RHHBY

Roche

$39.95 /

-0.32 (-0.79%)

, EYPT

EyePoint

$3.06 /

+0.02 (+0.66%)

, OCUL

Ocular Therapeutix

$2.80 /

-0.005 (-0.18%)

, CLSD

Clearside Biomedical

$1.16 /

+ (+0.00%)

, FDMT

4D Molecular

$24.00 /

+2.43 (+11.27%)

In conjunction with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APLS Apellis
$48.94 /

+1.27 (+2.66%)

ISEE Iveric bio
$21.08 /

+0.2 (+0.96%)

JNJ Johnson & Johnson
$177.38 /

+0.13 (+0.07%)

NVS Novartis
$91.10 /

-0.64 (-0.70%)

AKTX Akari Therapeutics
/

+

BLTE Belite Bio
$31.00 /

+0.6 (+1.97%)

LCTX Lineage Cell Therapeutics
$1.29 /

-0.02 (-1.53%)

OCGN Ocugen
$1.39 /

+0.015 (+1.09%)

REGN Regeneron
$774.25 /

+10.08 (+1.32%)

RHHBY Roche
$39.95 /

-0.32 (-0.79%)

EYPT EyePoint
$3.06 /

+0.02 (+0.66%)

OCUL Ocular Therapeutix
$2.80 /

-0.005 (-0.18%)

CLSD Clearside Biomedical
$1.16 /

+ (+0.00%)

FDMT 4D Molecular
$24.00 /

+2.43 (+11.27%)

APLS Apellis
$48.94 /

+1.27 (+2.66%)

11/18/22 Cowen
Apellis should trade to $70 upon pegectacoplan approval, says Cowen
11/10/22 Jefferies
Apellis downgraded to Hold at Jefferies after doctor survey
11/10/22 Jefferies
Iveric bio downgraded to Hold at Jefferies after doctor survey
11/10/22 Jefferies
Apellis downgraded to Hold from Buy at Jefferies
ISEE Iveric bio
$21.08 /

+0.2 (+0.96%)

11/10/22 Jefferies
Apellis downgraded to Hold at Jefferies after doctor survey
11/10/22 Jefferies
Iveric bio downgraded to Hold at Jefferies after doctor survey
11/10/22 Jefferies
Iveric bio downgraded to Hold from Buy at Jefferies
10/17/22 B. Riley
Iveric bio upgraded to Neutral at B. Riley after competitor in GA 'disappoints'
JNJ Johnson & Johnson
$177.38 /

+0.13 (+0.07%)

12/07/22 Piper Sandler
Horizon Therapeutics price target raised to $110 from $90 at Piper Sandler
12/01/22 Jefferies
Horizon Therapeutics price target raised to $125 from $101 at Jefferies
12/01/22 Morgan Stanley
Johnson & Johnson price target raised to $178 from $170 at Morgan Stanley
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
NVS Novartis
$91.10 /

-0.64 (-0.70%)

12/05/22 Stifel
Novartis upgraded to Buy from Hold at Stifel
10/26/22 JPMorgan
Novartis price target lowered to CHF 78 from CHF 81 at JPMorgan
10/14/22 Barclays
Novartis price target lowered to CHF 75 from CHF 85 at Barclays
10/07/22 Deutsche Bank
Novartis price target lowered to CHF 70 from CHF 75 at Deutsche Bank
AKTX Akari Therapeutics
/

+

12/05/22 H.C. Wainwright
Akari Therapeutics initiated with a Buy at H.C. Wainwright
11/01/22 Alliance Global Partners
Akari Therapeutics initiated with a Buy at Alliance Global Partners
BLTE Belite Bio
$31.00 /

+0.6 (+1.97%)

08/01/22 H.C. Wainwright
Belite Bio initiated with a Buy at H.C. Wainwright
07/01/22 Benchmark
Belite Bio initiated with a Buy at Benchmark
LCTX Lineage Cell Therapeutics
$1.29 /

-0.02 (-1.53%)

11/01/22 Baird
Baird starts Lineage Cell Therapeutics with an Outperform, $5 price target
11/01/22 Baird
Lineage Cell Therapeutics initiated with an Outperform at Baird
06/14/22 B. Riley
B. Riley starts 'deep value play' Lineage Cell with Buy, $4 target
06/14/22 B. Riley
Lineage Cell Therapeutics initiated with a Buy at B. Riley
OCGN Ocugen
$1.39 /

+0.015 (+1.09%)

08/23/22 Mizuho
Ocugen initiated with a Buy at Mizuho
08/15/22 H.C. Wainwright
Ocugen price target lowered to $6 from $7 at H.C. Wainwright
06/15/22 Roth Capital
Ocugen resumed at Buy at Roth Capital on COVAXIN and OCU400 potential
06/15/22 Roth Capital
Ocugen resumed at Buy from Neutral at Roth Capital
REGN Regeneron
$774.25 /

+10.08 (+1.32%)

11/09/22 RBC Capital
Regeneron Eylea IPR losses 'mostly anticipated,' says RBC Capital
11/09/22 Truist
Regeneron price target raised to $856 from $790 at Truist
11/03/22 Piper Sandler
Regeneron price target lowered to $765 from $775 at Piper Sandler
10/31/22 EF Hutton
Regeneron initiated with a Buy at EF Hutton
RHHBY Roche
$39.95 /

-0.32 (-0.79%)

12/07/22 Morgan Stanley
Roche price target lowered to CHF 330 from CHF 350 at Morgan Stanley
12/02/22 BofA
Hookipa Pharma downgraded to Underperform from Buy at BofA
11/29/22 Guggenheim
Roche bladder cancer indication withdrawal positive for Seagen, says Guggenheim
11/15/22 Truist
Biogen price target raised to $350 from $265 at Truist
EYPT EyePoint
$3.06 /

+0.02 (+0.66%)

08/31/22 Cantor Fitzgerald
Cantor says EyePoint negative stock reaction to 8-K 'overdone'
08/04/22 H.C. Wainwright
EyePoint price target raised to $25 from $24 at H.C. Wainwright
07/07/22 Chardan
EyePoint initiated with a Buy at Chardan
OCUL Ocular Therapeutix
$2.80 /

-0.005 (-0.18%)

11/08/22 H.C. Wainwright
Ocular Therapeutix price target lowered to $9 from $10 at H.C. Wainwright
11/08/22 Raymond James
Ocular Therapeutix price target lowered to $14 from $29 at Raymond James
09/29/22 Piper Sandler
Ocular Therapeutix data 'paint a compelling profile,' says Piper Sandler
09/27/22 Piper Sandler
Ocular Therapeutix hit/beat on Phase I study expectations, says Piper Sandler
CLSD Clearside Biomedical
$1.16 /

+ (+0.00%)

11/10/22 Needham
Clearside Biomedical upgraded to Buy from Hold at Needham
11/10/22 H.C. Wainwright
Clearside Biomedical price target raised to $6 from $5 at H.C. Wainwright
11/09/22 Stifel
Clearside Biomedical upgraded to Buy at Stifel after positive trial readout
11/09/22 Stifel
Clearside Biomedical upgraded to Buy from Hold at Stifel
FDMT 4D Molecular
$24.00 /

+2.43 (+11.27%)

11/18/22 H.C. Wainwright
4D Molecular initiated with a Buy at H.C. Wainwright
11/15/22 Goldman Sachs
4D Molecular upgraded to Buy from Neutral at Goldman Sachs
11/14/22 BofA
4D Molecular price target raised to $25 from $15 at BofA
11/14/22 Evercore ISI
4D Molecular price target raised to $45 from $32 at Evercore ISI
ISEE Iveric bio
$21.08 /

+0.2 (+0.96%)

JNJ Johnson & Johnson
$177.38 /

+0.13 (+0.07%)

NVS Novartis
$91.10 /

-0.64 (-0.70%)

AKTX Akari Therapeutics
/

+

LCTX Lineage Cell Therapeutics
$1.29 /

-0.02 (-1.53%)

OCGN Ocugen
$1.39 /

+0.015 (+1.09%)

REGN Regeneron
$774.25 /

+10.08 (+1.32%)

RHHBY Roche
$39.95 /

-0.32 (-0.79%)

EYPT EyePoint
$3.06 /

+0.02 (+0.66%)

OCUL Ocular Therapeutix
$2.80 /

-0.005 (-0.18%)

CLSD Clearside Biomedical
$1.16 /

+ (+0.00%)

FDMT 4D Molecular
$24.00 /

+2.43 (+11.27%)

  • 01
    Dec
  • 29
    Apr
  • 24
    Mar
  • 23
    Feb
JNJ Johnson & Johnson
$177.38 /

+0.13 (+0.07%)

NVS Novartis
$91.10 /

-0.64 (-0.70%)

REGN Regeneron
$774.25 /

+10.08 (+1.32%)

RHHBY Roche
$39.95 /

-0.32 (-0.79%)

APLS Apellis
$48.94 /

+1.27 (+2.66%)

ISEE Iveric bio
$21.08 /

+0.2 (+0.96%)

JNJ Johnson & Johnson
$177.38 /

+0.13 (+0.07%)

NVS Novartis
$91.10 /

-0.64 (-0.70%)

BLTE Belite Bio
$31.00 /

+0.6 (+1.97%)

LCTX Lineage Cell Therapeutics
$1.29 /

-0.02 (-1.53%)

OCGN Ocugen
$1.39 /

+0.015 (+1.09%)

REGN Regeneron
$774.25 /

+10.08 (+1.32%)

RHHBY Roche
$39.95 /

-0.32 (-0.79%)

OCUL Ocular Therapeutix
$2.80 /

-0.005 (-0.18%)

FDMT 4D Molecular
$24.00 /

+2.43 (+11.27%)

APLS Apellis
$48.94 /

+1.27 (+2.66%)

ISEE Iveric bio
$21.08 /

+0.2 (+0.96%)

JNJ Johnson & Johnson
$177.38 /

+0.13 (+0.07%)

NVS Novartis
$91.10 /

-0.64 (-0.70%)

OCGN Ocugen
$1.39 /

+0.015 (+1.09%)

REGN Regeneron
$774.25 /

+10.08 (+1.32%)

Conference/Events
JPMorgan aviation analyst to hold an analyst/industry conference call » 11:23
12/08/22
12/08
11:23
12/08/22
11:23

Airlines & Aircraft…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Context Therapeutics price target lowered to $4 from $6 at H.C. Wainwright » 11:22
12/08/22
12/08
11:22
12/08/22
11:22
CNTX

Context Therapeutics

$1.05 /

-0.31 (-22.79%)

H.C. Wainwright analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNTX Context Therapeutics
$1.05 /

-0.31 (-22.79%)

CNTX Context Therapeutics
$1.05 /

-0.31 (-22.79%)

01/24/22 ThinkEquity
Context Therapeutics initiated with a Buy at ThinkEquity
Conference/Events
JPMorgan business/info services analyst holds analyst/industry conference call » 11:18
12/08/22
12/08
11:18
12/08/22
11:18

Business &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Technical Analysis
NASDAQ market internals summary » 11:17
12/08/22
12/08
11:17
12/08/22
11:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 11:16
12/08/22
12/08
11:16
12/08/22
11:16
$NYE

NYSE Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Periodicals
Spirit reaches agreement in principle on new pilot contract, Bloomberg says » 11:15
12/08/22
12/08
11:15
12/08/22
11:15
SAVE

Spirit Airlines

$20.41 /

-0.02 (-0.10%)

Spirit Air and its pilots…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAVE Spirit Airlines
$20.41 /

-0.02 (-0.10%)

SAVE Spirit Airlines
$20.41 /

-0.02 (-0.10%)

11/01/22 Citi
Spirit Airlines price target raised to $23 from $22 at Citi
09/30/22 Citi
Spirit Airlines reinstated with a Neutral at Citi (yesterday)
09/08/22 Raymond James
Frontier Group downgraded to Market Perform from Outperform at Raymond James
08/15/22 Melius Research
Spirit Airlines initiated with a Hold at Melius Research
SAVE Spirit Airlines
$20.41 /

-0.02 (-0.10%)

SAVE Spirit Airlines
$20.41 /

-0.02 (-0.10%)

SAVE Spirit Airlines
$20.41 /

-0.02 (-0.10%)

SAVE Spirit Airlines
$20.41 /

-0.02 (-0.10%)

Conference/Events
Jefferies retail/tech analyst to hold an analyst/industry conference call » 11:14
12/08/22
12/08
11:14
12/08/22
11:14

Retail/Tech Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:08
12/08/22
12/08
11:08
12/08/22
11:08
SMMT

Summit Therapeutics

$3.71 /

+0.61 (+19.68%)

, CKPT

Checkpoint Therapeutics

$3.99 /

-0.15 (-3.62%)

, BCDA

BioCardia

$1.70 /

-0.01 (-0.58%)

, GMDA

Gamida Cell

$1.29 /

+0.01 (+0.78%)

, GOSS

Gossamer Bio

$2.20 /

+0.045 (+2.09%)

These names in the…

ShowHide Related Items >><<
SMMT Summit Therapeutics
$3.71 /

+0.61 (+19.68%)

CKPT Checkpoint Therapeutics
$3.99 /

-0.15 (-3.62%)

BCDA BioCardia
$1.70 /

-0.01 (-0.58%)

GMDA Gamida Cell
$1.29 /

+0.01 (+0.78%)

GOSS Gossamer Bio
$2.20 /

+0.045 (+2.09%)

SMMT Summit Therapeutics
$3.71 /

+0.61 (+19.68%)

CKPT Checkpoint Therapeutics
$3.99 /

-0.15 (-3.62%)

07/14/22 B. Riley
Checkpoint Therapeutics resumed with a Buy at B. Riley
06/17/22 Lake Street
Checkpoint cosibelimab data 'competitive,' says Lake Street
06/07/22 Lake Street
Lake Street says Checkpoint warrants interest after cosibelimab 'shines' at ASCO
05/31/22 Cantor Fitzgerald
Cantor sees 'positive' data likely coming from Checkpoint Therapeutics in June
BCDA BioCardia
$1.70 /

-0.01 (-0.58%)

11/17/22 Alliance Global Partners
BioCardia price target lowered to $6 from $11.50 at Alliance Global Partners
11/11/22 Dawson James
BioCardia downgraded to Neutral from Buy at Dawson James
12/20/21 H.C. Wainwright
BioCardia initiated with a Buy at H.C. Wainwright
GMDA Gamida Cell
$1.29 /

+0.01 (+0.78%)

11/15/22 Oppenheimer
Gamida Cell price target lowered to $10 from $15 at Oppenheimer
10/02/22 Piper Sandler
Piper Sandler keeps Overweight on Gamida Cell, lowers price target to $7
08/15/22 Piper Sandler
Gamida Cell price target raised to $8 from $6 at Piper Sandler
08/10/22 H.C. Wainwright
H.C. Wainwright a buyer of Gamida Cell ahead of omidubicel PDUFA date
GOSS Gossamer Bio
$2.20 /

+0.045 (+2.09%)

06:23 Today H.C. Wainwright
Gossamer Bio price target lowered to $5 from $25 at H.C. Wainwright
12/07/22 BofA
Gossamer Bio price target lowered to $7 from $15 at BofA
12/07/22 JPMorgan
Gossamer Bio downgraded to Underweight from Neutral at JPMorgan
12/07/22 Barclays
Gossamer Bio downgraded to Equal Weight from Overweight at Barclays
SMMT Summit Therapeutics
$3.71 /

+0.61 (+19.68%)

CKPT Checkpoint Therapeutics
$3.99 /

-0.15 (-3.62%)

BCDA BioCardia
$1.70 /

-0.01 (-0.58%)

GMDA Gamida Cell
$1.29 /

+0.01 (+0.78%)

GOSS Gossamer Bio
$2.20 /

+0.045 (+2.09%)

  • 28
    Sep
CKPT Checkpoint Therapeutics
$3.99 /

-0.15 (-3.62%)

GMDA Gamida Cell
$1.29 /

+0.01 (+0.78%)

GOSS Gossamer Bio
$2.20 /

+0.045 (+2.09%)

SMMT Summit Therapeutics
$3.71 /

+0.61 (+19.68%)

Conference/Events
Jefferies software/Internet analyst to hold analyst/industry conference call » 11:06
12/08/22
12/08
11:06
12/08/22
11:06
ADBE

Adobe

$333.10 /

+6.39 (+1.96%)

Software & Internet…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADBE Adobe
$333.10 /

+6.39 (+1.96%)

ADBE Adobe
$333.10 /

+6.39 (+1.96%)

10/19/22 RBC Capital
Adobe price target lowered to $395 from $425 at RBC Capital
10/19/22 Credit Suisse
Adobe price target lowered to $325 from $350 at Credit Suisse
10/19/22 Jefferies
Adobe price target lowered to $420 from $440 at Jefferies
10/17/22 BMO Capital
Adobe price target lowered to $332 from $345 at BMO Capital
ADBE Adobe
$333.10 /

+6.39 (+1.96%)

ADBE Adobe
$333.10 /

+6.39 (+1.96%)

ADBE Adobe
$333.10 /

+6.39 (+1.96%)

ADBE Adobe
$333.10 /

+6.39 (+1.96%)

Hot Stocks
Spearline acquires Callstats from 8x8, terms not disclosed » 11:05
12/08/22
12/08
11:05
12/08/22
11:05
EGHT

8x8

$4.37 /

+0.165 (+3.92%)

Spearline has acquired…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EGHT 8x8
$4.37 /

+0.165 (+3.92%)

EGHT 8x8
$4.37 /

+0.165 (+3.92%)

12/02/22 Craig-Hallum
Craig-Hallum sees 'tremendous logic' in RingCentral, 8x8 combination
10/28/22 Barclays
8x8 price target lowered to $4 from $5 at Barclays
10/28/22 Mizuho
8x8 price target lowered to $5 from $6 at Mizuho
10/11/22 Morgan Stanley
8x8 price target lowered to $4 from $6.50 at Morgan Stanley
EGHT 8x8
$4.37 /

+0.165 (+3.92%)

EGHT 8x8
$4.37 /

+0.165 (+3.92%)

Periodicals
Amazon rolls out TikTok-like feature called Inspire, WSJ reports » 11:05
12/08/22
12/08
11:05
12/08/22
11:05
AMZN

Amazon.com

$90.40 /

+1.97 (+2.23%)

Amazon is rolling out…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$90.40 /

+1.97 (+2.23%)

AMZN Amazon.com
$90.40 /

+1.97 (+2.23%)

06:56 Today Citi
DoD contracts shows competitiveness of cloud industry, says Citi
12/06/22 Oppenheimer
Oppenheimer remains very positive on AWS long-term despite macro weakness
12/01/22 Cowen
Amazon.com price target raised to $160 from $150 at Cowen
11/30/22 JMP Securities
JMP Securities encouraged by Amazon.com's focus on innovation
AMZN Amazon.com
$90.40 /

+1.97 (+2.23%)

AMZN Amazon.com
$90.40 /

+1.97 (+2.23%)

AMZN Amazon.com
$90.40 /

+1.97 (+2.23%)

AMZN Amazon.com
$90.40 /

+1.97 (+2.23%)

Hot Stocks
Disney announces ad-supported Disney+ plan available in the U.S. » 11:03
12/08/22
12/08
11:03
12/08/22
11:03
DIS

Disney

$92.69 /

+0.55 (+0.60%)

Disney+ made its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$92.69 /

+0.55 (+0.60%)

DIS Disney
$92.69 /

+0.55 (+0.60%)

11/30/22 Atlantic Equities
Atlantic Equities sees 'no easy fix' for Iger at Disney
11/22/22 Tigress Financial
Disney price target lowered to $177 from $229 at Tigress Financial
11/21/22 JPMorgan
JPMorgan 'reluctant to recommend chasing' Disney shares on rally
11/21/22 Citi
Iger returning 'unalloyed positive' for Disney shares, says Citi
DIS Disney
$92.69 /

+0.55 (+0.60%)

DIS Disney
$92.69 /

+0.55 (+0.60%)

DIS Disney
$92.69 /

+0.55 (+0.60%)

DIS Disney
$92.69 /

+0.55 (+0.60%)

Conference/Events
JPMorgan large/smid cap biotech analysts hold analyst/industry conference call » 10:59
12/08/22
12/08
10:59
12/08/22
10:59

SMid & Large Cap…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
JPMorgan business services analyst to hold analyst/industry conference call » 10:55
12/08/22
12/08
10:55
12/08/22
10:55

Business Services Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Wall Street opened in the green » 10:55
12/08/22
12/08
10:55
12/08/22
10:55
$ECON

Economic Data

/

+

Wall Street opened in the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Conference/Events
JPMorgan integrated oils analyst to hold an analyst/industry conference call » 10:51
12/08/22
12/08
10:51
12/08/22
10:51

Integrated Oils &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

General news
Week of 12/2 EIA natural gas report 21bcf  10:48
12/08/22
12/08
10:48
12/08/22
10:48
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Options
Beyond Meat call volume above normal and directionally bullish » 10:45
12/08/22
12/08
10:45
12/08/22
10:45
BYND

Beyond Meat

$16.54 /

+0.91 (+5.82%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BYND Beyond Meat
$16.54 /

+0.91 (+5.82%)

BYND Beyond Meat
$16.54 /

+0.91 (+5.82%)

11/28/22 Barclays
Beyond Meat downgraded to Underweight from Equal Weight at Barclays
11/23/22 Goldman Sachs
Beyond Meat price target lowered to $5 from $14 at Goldman Sachs
11/10/22 Bernstein
Beyond Meat price target lowered to $10 from $22 at Bernstein
11/10/22 Mizuho
Beyond Meat price target lowered to $11 from $27 at Mizuho
BYND Beyond Meat
$16.54 /

+0.91 (+5.82%)

BYND Beyond Meat
$16.54 /

+0.91 (+5.82%)

BYND Beyond Meat
$16.54 /

+0.91 (+5.82%)

BYND Beyond Meat
$16.54 /

+0.91 (+5.82%)

General news
The U.S. QSS figures » 10:45
12/08/22
12/08
10:45
12/08/22
10:45
$ECON

Economic Data

/

+

The U.S. QSS figures that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.